Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis

被引：0
|
作者：
Frikha, Fatma [1 ]
Boudaya, Sonia [1 ]
Bahloul, Emna [1 ]
Amouri, Meriem [1 ]
Turki, Hamida [1 ]
机构：
[1] Hop Hedi Chaker, Serv Dermatol Venereol, Ave Ain, Sfax 3089, Tunisia
来源：
THERAPIE | 2020年 / 75卷 / 03期
关键词：
Cutaneous leishmaniasis; Glucantime; Meglumine antimoniate; Side effects; Infant; Children; HIGH-FREQUENCY; CHILDREN; PHARMACOKINETICS;
D O I：
10.1016/j.therap.2019.05.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：314 / 316
页数：4
相关论文
共 50 条
  • [41] The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis
    Asilian, A
    Sadeghinia, A
    Faghihi, G
    Momeni, A
    Harandi, AA
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2003, 97 (05): : 493 - 498
  • [42] Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate
    Momeni, AZ
    Reiszadae, MR
    Aminjavaheri, M
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (07) : 441 - 443
  • [43] Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis
    Yesilova, Yavuz
    Surucu, Hacer Altin
    Ardic, Nurittin
    Aksoy, Mustafa
    Yesilova, Abdullah
    Oghumu, Steve
    Satoskar, Abhay R.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (01) : 83 - 87
  • [44] Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
    Rojas Cabrera, Ernesto
    Verduguez-Orellana, Aleida
    Tordoya-Titichoca, Igberto J.
    Sejas, Ccoya
    Ledezma, Rebeca
    Alvarez, Ingrid
    Limachi-Choque, Jhonny
    Ortuno-Gutierrez, Nimer
    Cordova Rojas, Marisol
    Guzman-Rivero, Miguel
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (10)
  • [45] RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
    Ferreira e Vasconcellos, Erica de Camargo
    Fernandes Pimentel, Maria Ines
    Valete-Rosalino, Claudia Maria
    Madeira, Maria de Fatima
    Schubach, Armando de Oliveira
    [J]. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2014, 56 (04): : 361 - 362
  • [46] Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial
    Machado, Paulo R. L.
    Ribeiro, Camila S.
    Franca-Costa, Jaqueline
    Dourado, Mayra E. F.
    Trinconi, Cristiana T.
    Yokoyama-Yasunaka, Jenicer K. U.
    Malta-Santos, Hayna
    Borges, Valeria M.
    Carvalho, Edgar M.
    Uliana, Silvia R. B.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2018, 23 (09) : 936 - 942
  • [47] Comparative Efficacy of Intralesional Chloroquine With Intralesional Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
    Ullah, Obed
    Rizwan, Muhammad
    Raza, Naeem
    Zulfiqar, Sumeera
    Akbar, Nadia
    Ullah, Habib
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [48] Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
    Yazdanpanah, Mohamad Javad
    Banihashemi, Mahnaz
    Pezeshkpoor, Fakhrozaman
    Khajedaluee, Mohammad
    Famili, Sororozaman
    Rodi, Iman Tavakoli
    Yousefzadeh, Hadis
    [J]. DERMATOLOGY RESEARCH AND PRACTICE, 2011, 2011
  • [49] Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru
    Miranda-Verástegui, C
    Llanos-Cuentas, A
    Arévalo, I
    Ward, BJ
    Matlashewski, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) : 1395 - 1403
  • [50] Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis
    Iraji, F
    Vali, A
    Asilian, A
    Shahtalebi, MA
    Momeni, AZ
    [J]. DERMATOLOGY, 2004, 209 (01) : 46 - 49
12345